SBIR/STTR Research Award

Inhibitors of isoprenoid synthesis for antibacterial therapy

Award identifier dd60a6758a14b8ecfe17b6b909a4a24be636cb2384810fc3e9d9e01bb8a9e6c0Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$145,205

Program and phase

SBIR · Phase I

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Specific Diagnostics, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
N7RLPSHLM4E5
Solicitation number
PA12-088
Topic code
NCI

Research abstract

DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer deaths worldwide. The high mortality is in part due to the lack of good tests for early detection and treatment. Our technology diagnoses the presence of cancer via analysis ofthe specific fingerprint of volatile organic molecules produced by tumor metabolism, out- gassed from tumor tissue to blood and excreted in urine. Specific Technologies has pioneered a novel, highly sensitive and high dimensional chemical sensor array which in some respects mimics biological olfactory sensing, in that exposure to volatile molecules produces a complex sensor pattern allows even complex mixtures to be discriminated. Motivated by recent studies demonstrating that canines presented with urinesamples can be trained to detect early stage cancer with high accuracy, we present preliminary data suggesting that our VOC-sensitive sensor responds with patterns discriminative of lung cancer when exposed urine headspace gas. If confirmed in more extensive testing, this assay would offer a non-invasive, rapid (1 hour), low-cost (order 10), point-of-care diagnostic for early stage lung cancer which we believe will be of significant value across a wide range of clinical settings, initially serving as an adjunct diagnostic for patients wth indeterminate pulmonary nodules, perhaps eventually allowing for lung cancer pre-screening in high-risk individuals. This assay of the presence of active tumor metabolism may also enable non-invasive and inexpensive monitoring of the efficacy of chemotherapy. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: The proposed research effort will develop an assay of the headspace gas of a small urine sample as a rapid, inexpensive and non-invasive diagnostic test for the presence of lung cancer, initially as a follow up of CT with indeterminate nodules. A further application of this technology would be a urine headspace analysis to non-invasively and inexpensively monitor the efficacy of chemotherapy treatment. Page 1

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

5 SBIR/STTR records share this UEI (2013–2021). Reported award amounts total $9,341,541. Reported amounts are not federal obligations.

Phases: Phase II – Direct to Phase II, Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.